Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04323631
Recruitment Status : Withdrawn (Trial not started due to accumulating evidence against HCQ for COVID)
First Posted : March 26, 2020
Last Update Posted : June 30, 2020
Rabin Medical Center
Information provided by (Responsible Party):
Rambam Health Care Campus

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : April 30, 2020
Actual Study Completion Date : April 30, 2020